Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction.

By Michael E. Davis, P. Hsieh, Tomosaburo Takahashi, Q. Song, Shuguang Zhang, Roger D. Kamm, Alan J. Grodzinsky, P. Anversa, Richard T. Lee. Proceedings of the National Academy of Sciences of the United States of America, 2006

615 citations recorded by the source corpus.